Home » Topics » Regulatory » Patents

Patents
RSS

Sichuan Kelun-Biotech Biopharmaceutical presents new PPAR receptor agonists

Sep. 22, 2021

Dual SYK/VEGFR2 inhibitors discovered at Ocumension Therapeutics

Sep. 22, 2021

New HIV replication inhibitors discovered at Gilead

Sep. 21, 2021

Remix Therapeutics patents RNA splicing modulators

Sep. 21, 2021

New PBP3 ligands identified at Bicycletx

Sep. 21, 2021

UCB describes new IL-17 modulators

Sep. 21, 2021

Kissei Pharmaceutical discovers EGLN1 inhibitors

Sep. 20, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents antibodies binding IL-4RA

Sep. 20, 2021

New GCN2 inhibitors identified at Black Belt TX

Sep. 20, 2021

Gilead describes new antiviral nucleoside analogues

Sep. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...